Interview: Carlos Pérez Munguía – CEO at NYCE, Mexico

077ee13b0065bc5e31858fdcd9adadd32eb866f58fa7349678pimgpsh_fullsize_distrCarlos Pérez Muguía, CEO at NYCE, showcases the increasing added value brought by this leading Cofepris’ authorized third party (ATP) to the healthcare industry, the future objectives of the company to enter into the biotech field, and its readiness to continue helping Cofepris in other areas to further strengthen Mexico’s healthcare eco-system. Could you please introduce to our international readers the key operations of NYCE as well as the company’s milestones during the last five years?
"Our mix of revenues of pharmaceutical versus medical devices has varied throughout the last three years, hand in hand with the performance of each industry."
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report